Woodline Partners’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
122,833
+698
| +0.6% | +$879 | ﹤0.01% | 906 |
|
|
2025
Q1 | $112K | Hold |
122,135
| – | – | ﹤0.01% | 887 |
|
|
2024
Q4 | $194K | Hold |
122,135
| – | – | ﹤0.01% | 906 |
|
|
2024
Q3 | $239K | Sell |
122,135
-113,296
| -48% | -$222K | ﹤0.01% | 562 |
|
|
2024
Q2 | $386K | Sell |
235,431
-1,846
| -0.8% | -$3.03K | ﹤0.01% | 504 |
|
|
2024
Q1 | $1.22M | Sell |
237,277
-903,394
| -79% | -$4.64M | 0.01% | 448 |
|
|
2023
Q4 | $6.54M | Buy |
1,140,671
+679,133
| +147% | +$3.89M | 0.07% | 280 |
|
|
2023
Q3 | $2.21M | Buy |
+461,538
| New | +$2.21M | 0.03% | 388 |
|
|
2022
Q3 | – | Sell |
-68,802
| Closed | -$374K | – | 766 |
|
|
2022
Q2 | $374K | Hold |
68,802
| – | – | 0.01% | 587 |
|
|
2022
Q1 | $632K | Hold |
68,802
| – | – | 0.01% | 507 |
|
|
2021
Q4 | $1.04M | Sell |
68,802
-50,471
| -42% | -$761K | 0.01% | 499 |
|
|
2021
Q3 | $2.85M | Buy |
+119,273
| New | +$2.85M | 0.05% | 353 |
|